POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.

Menzies, Alexander M; Long, Georgina V; Kohn, Amiee; Tawbi, Hussein; Weber, Jeffrey; Flaherty, Keith; McArthur, Grant A; Ascierto, Paolo A; Pfluger, Yanina; Lewis, Karl; Tsai, Katy K; Hamid, Omid; Prenen, Hans; Fein, Luis; Wang, Erjian; Guenzel, Carolin; Zhang, Fan; Kleha, Joseph F; Pietro, Alessandra di; Davies, Michael A

Neuro-Oncology Advances, 2024, Vol 6, Issue 1, p1

Academic Journal

10.1093/noajnl/vdae033